vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and SR Bancorp, Inc. (SRBK). Click either name above to swap in a different company.

SR Bancorp, Inc. is the larger business by last-quarter revenue ($8.4M vs $6.2M, roughly 1.3× Alector, Inc.). On growth, SR Bancorp, Inc. posted the faster year-over-year revenue change (6.4% vs -88.5%). SR Bancorp, Inc. produced more free cash flow last quarter ($3.1M vs $-184.1M). Over the past eight quarters, SR Bancorp, Inc.'s revenue compounded faster (-2.4% CAGR vs -37.4%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

SR Bancorp Inc. is a regional bank holding company based in the United States. It offers a full range of consumer and commercial banking services including deposit products, personal loans, mortgage lending, small business financing, and commercial credit solutions, primarily serving local communities and small to mid-sized enterprises in its operating areas.

ALEC vs SRBK — Head-to-Head

Bigger by revenue
SRBK
SRBK
1.3× larger
SRBK
$8.4M
$6.2M
ALEC
Growing faster (revenue YoY)
SRBK
SRBK
+94.9% gap
SRBK
6.4%
-88.5%
ALEC
More free cash flow
SRBK
SRBK
$187.2M more FCF
SRBK
$3.1M
$-184.1M
ALEC
Faster 2-yr revenue CAGR
SRBK
SRBK
Annualised
SRBK
-2.4%
-37.4%
ALEC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ALEC
ALEC
SRBK
SRBK
Revenue
$6.2M
$8.4M
Net Profit
$834.0K
Gross Margin
Operating Margin
13.0%
Net Margin
10.0%
Revenue YoY
-88.5%
6.4%
Net Profit YoY
-1696.9%
-18.3%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
SRBK
SRBK
Q4 25
$6.2M
$8.4M
Q3 25
$3.3M
$8.2M
Q2 25
$7.9M
$7.6M
Q1 25
$3.7M
$7.7M
Q4 24
$54.2M
$7.9M
Q3 24
$15.3M
$8.4M
Q2 24
$15.1M
$7.9M
Q1 24
$15.9M
$8.8M
Net Profit
ALEC
ALEC
SRBK
SRBK
Q4 25
$834.0K
Q3 25
$-34.7M
$693.0K
Q2 25
$-30.5M
$2.2M
Q1 25
$-40.5M
$537.0K
Q4 24
$-2.1M
$1.0M
Q3 24
$-42.2M
$1.4M
Q2 24
$-38.7M
$-3.0M
Q1 24
$-36.1M
$1.1M
Operating Margin
ALEC
ALEC
SRBK
SRBK
Q4 25
13.0%
Q3 25
-1153.6%
11.0%
Q2 25
-433.6%
32.1%
Q1 25
-1216.5%
8.1%
Q4 24
-13.4%
17.1%
Q3 24
-315.7%
20.6%
Q2 24
-302.4%
-34.0%
Q1 24
-275.0%
15.4%
Net Margin
ALEC
ALEC
SRBK
SRBK
Q4 25
10.0%
Q3 25
-1063.4%
8.5%
Q2 25
-387.7%
29.2%
Q1 25
-1101.6%
7.0%
Q4 24
-3.8%
13.0%
Q3 24
-275.2%
16.3%
Q2 24
-256.4%
-38.2%
Q1 24
-227.0%
12.1%
EPS (diluted)
ALEC
ALEC
SRBK
SRBK
Q4 25
$0.11
Q3 25
$-0.34
$0.09
Q2 25
$-0.30
$0.27
Q1 25
$-0.41
$0.06
Q4 24
$-0.02
$0.12
Q3 24
$-0.43
$0.16
Q2 24
$-0.40
$8.14
Q1 24
$-0.38
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
SRBK
SRBK
Cash + ST InvestmentsLiquidity on hand
$256.0M
$81.8M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$188.5M
Total Assets
$293.2M
$1.1B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
SRBK
SRBK
Q4 25
$256.0M
$81.8M
Q3 25
$291.1M
$58.3M
Q2 25
$307.3M
$57.8M
Q1 25
$354.6M
$62.2M
Q4 24
$413.4M
$53.4M
Q3 24
$457.2M
$47.3M
Q2 24
$503.3M
$45.9M
Q1 24
$562.1M
$72.5M
Total Debt
ALEC
ALEC
SRBK
SRBK
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
SRBK
SRBK
Q4 25
$30.6M
$188.5M
Q3 25
$57.7M
$191.9M
Q2 25
$71.2M
$193.8M
Q1 25
$94.6M
$195.1M
Q4 24
$126.8M
$198.1M
Q3 24
$118.9M
$200.5M
Q2 24
$150.6M
$199.5M
Q1 24
$178.9M
$199.3M
Total Assets
ALEC
ALEC
SRBK
SRBK
Q4 25
$293.2M
$1.1B
Q3 25
$335.3M
$1.1B
Q2 25
$356.4M
$1.1B
Q1 25
$408.3M
$1.1B
Q4 24
$468.3M
$1.1B
Q3 24
$516.0M
$1.1B
Q2 24
$570.7M
$1.0B
Q1 24
$635.5M
$1.1B
Debt / Equity
ALEC
ALEC
SRBK
SRBK
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
SRBK
SRBK
Operating Cash FlowLast quarter
$-184.0M
$3.6M
Free Cash FlowOCF − Capex
$-184.1M
$3.1M
FCF MarginFCF / Revenue
-2951.3%
37.0%
Capex IntensityCapex / Revenue
0.7%
5.9%
Cash ConversionOCF / Net Profit
4.31×
TTM Free Cash FlowTrailing 4 quarters
$-326.5M
$11.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
SRBK
SRBK
Q4 25
$-184.0M
$3.6M
Q3 25
$-32.5M
$1.2M
Q2 25
$-49.0M
$4.7M
Q1 25
$-60.8M
$2.6M
Q4 24
$-55.0M
$-1.4M
Q3 24
$-50.7M
$1.8M
Q2 24
$-62.8M
$-1.7M
Q1 24
$-61.3M
$-3.9M
Free Cash Flow
ALEC
ALEC
SRBK
SRBK
Q4 25
$-184.1M
$3.1M
Q3 25
$-32.5M
$1.1M
Q2 25
$-49.1M
$4.2M
Q1 25
$-60.8M
$2.5M
Q4 24
$-55.2M
$-1.5M
Q3 24
$-50.9M
$1.7M
Q2 24
$-63.1M
$-2.8M
Q1 24
$-61.9M
$-4.0M
FCF Margin
ALEC
ALEC
SRBK
SRBK
Q4 25
-2951.3%
37.0%
Q3 25
-997.6%
14.0%
Q2 25
-623.0%
55.9%
Q1 25
-1655.0%
32.3%
Q4 24
-101.8%
-19.5%
Q3 24
-332.1%
20.3%
Q2 24
-418.6%
-35.8%
Q1 24
-389.3%
-45.2%
Capex Intensity
ALEC
ALEC
SRBK
SRBK
Q4 25
0.7%
5.9%
Q3 25
0.3%
0.9%
Q2 25
0.1%
5.7%
Q1 25
0.5%
1.0%
Q4 24
0.3%
1.3%
Q3 24
1.4%
1.0%
Q2 24
2.2%
13.9%
Q1 24
3.4%
0.5%
Cash Conversion
ALEC
ALEC
SRBK
SRBK
Q4 25
4.31×
Q3 25
1.76×
Q2 25
2.11×
Q1 25
4.79×
Q4 24
-1.40×
Q3 24
1.31×
Q2 24
Q1 24
-3.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons